PLENARY D
CHANGING THE RESEARCH SYSTEM
Chair: Mark Frankel, American Association for the Advancement of Science, US

	video	file
SIX CHANGES IN THE RESEARCH SYSTEM TO REINFORCE INTEGRITY: EVOLVING RESEARCH ASSESSMENT IN CHINA Wei Yang, National Natural Sciences Foundation, China
DOPING DOCTORS: MARKETING STRATEGIES OF GLOBAL PHARMACEUTICAL COMPANIES IN JAPAN Iekuni Ichikawa, Vanderbilt University, US
HY IS WASTE IN RESEARCH AN ETHICAL ISSUE? Elizabeth Wager, Sideview, UK

PLENARY E
THE ROLE OF FUNDERS IN DRIVING CHANGE IN THE RESEARCH SYSTEM
Chair: Nicholas Steneck, University of Michigan, US

	video	file
CHALLENGES IN PROMOTING THE RESPONSIBLE CONDUCT OF RESEARCH: PERSPECTIVES OF PUBLIC FUNDERS Susan Zimmerman, Secretariat on Responsible Conduct of Research, Canada
RESEARCH INTEGRITY: WHAT IS A SCIENCE FUNDER TO DO? Kevin Moses, Wellcome Trust, U
COLLABORATING FOR HEALTHIER LIVES -- THE PATIENTS ARE WAITING: THE PHARMACEUTICAL INDUSTRY’S ROLE IN FOSTERING RESEARCH INTEGRITY AND CREATING BETTER SYSTEMS David Gallacher, Janssen, Belgium